Invasive Respiratory Support

Published on 13/02/2015 by admin

Filed under Cardiothoracic Surgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 2 (3 votes)

This article have been viewed 7172 times

Chapter 29 Invasive Respiratory Support

Invasive ventilation is positive pressure ventilation applied via an endotracheal or tracheotomy tube. Most patients undergoing cardiac surgery do not have pulmonary disease and require invasive ventilation only until they have recovered from the surgery enough to be awakened. The ventilatory management of these patients is discussed in Chapter 17. In this chapter, the focus is on the care of patients with severe respiratory or cardiac disease who require prolonged and often complex forms of ventilation.

In the first part of the chapter the pathophysiologic effects of positive pressure ventilation are discussed. In the second part the principles of ventilator function are described. In the third part, ventilatory strategies in specific clinical situations, weaning ventilation, and tracheotomies are discussed. Because cardiothoracic intensive care units (ICUs) are often centers for mechanical cardiorespiratory support (see Chapter 22), a discussion of advanced ventilatory therapies, such as prone positioning and highfrequency oscillation, is also included. The indications for invasive ventilation are outlined in Chapter 27.

PATHOPHYSIOLOGY OF POSITIVE PRESSURE VENTILATION

In normal breathing, as the chest cavity expands during inspiration a negative pressure is generated within the alveoli, which draws air into the lungs. With invasive (or noninvasive) ventilation, positive pressure is applied to the airway and gas is blown into the lungs. Invasive ventilation is therefore nonphysiologic and has important respiratory and cardiac effects.1

Respiratory Effects

Ventilator-Induced Lung Injury

In certain circumstances, positive pressure ventilation can cause or contribute to acute lung injury.3 Patients most at risk for ventilator-induced lung injury are those with severe systemic (e.g., sepsis) or pulmonary (e.g., pneumonia) disease who are ventilated with large tidal volumes, high airway pressures, inadequate levels of PEEP, and high inspired oxygen concentrations.4 The mechanisms of ventilator-induced lung injury are complex but involve an exacerbation of systemic inflammation5 and physical trauma to the alveoli due to overdistension and the repeated opening and closing of lung units.6 Crude mortality rate in critically ill patients ventilated with high tidal volumes (12 ml/kg) is 9% higher than the rate in those ventilated with low tidal volumes (6 ml/kg).7 This observation has led to the concept of lung-protective ventilation, which is described subsequently.

Cardiac Effects

The main direct effects of positive ventilation on the cardiovascular system are reduced systemic venous return,8 altered right ventricular afterload,9 and reduced left ventricular afterload.10 The impact of these effects is determined by the particular patient’s underlying cardiac function and intravascular volume status. Positive pressure ventilation performed properly eliminates or substantially reduces the work of breathing, which also has an indirect positive effect on cardiovascular function.

Other Effects

Positive pressure ventilation results in reduced secretion of atrial natriuretic peptide, which leads to sodium and water retention by the kidney.12 Patients who undergo prolonged positive pressure ventilation typically retain significant amounts of sodium and water.

VENTILATOR MODES AND CONTROLS

Ventilators have become very complex and have a bewildering array of modes and controls,13 despite a lack of evidence of improved outcomes.14 Further confusion is created because manufacturers call similar ventilatory modes different names.

At its most simple, invasive ventilation involves mandatory machine-delivered breaths of a given volume (or pressure), in which controls for fractional inspired oxygen (FIo2), breath rate, breath volume (or pressure), and the ratio of inspiratory time to expiratory time (the I:E ratio) are set.15 For this type of mandatory ventilation to succeed, the patient’s respiratory system must be entirely passive. Much of the complexity of modern ventilators comes from the desire to allow patients to take spontaneous breaths that are assisted by and synchronized with the ventilator.

The following parameters apply to all modern ventilators: (1) inspiratory flow generation; (2) cycling; (3) triggering; (4) mode; (5) PEEP.

Inspiratory Flow Generation: Volume Control or Pressure Control

Volume control ventilation provides a constant inspiratory flow to achieve a predefined tidal volume (Fig. 29-2). Airway pressure varies with inspiratory time and changes in lung compliance and airway resistance. When setting the ventilator in volume control mode, a tidal volume of 6 to 8 ml/kg should be chosen.

Pressure control ventilation provides a constant inspiratory pressure, which generates a decelerating inspiratory flow pattern (see Fig. 29-2). Tidal volume varies with inspiratory time and changes in lung compliance and airway resistance. The decelerating flow pattern distributes ventilation more evenly throughout the lung; in patients with V/Q mismatch, this improves oxygenation. It also allows some compensation for air leaks and limits inspiratory pressures, which helps to prevent ventilator-induced lung injury and barotrauma. The inspiratory pressure is chosen to achieve the desired tidal volume, usually 6 to 8 ml/kg, which typically requires a pressure of 15 to 30 cm H2O.16

Volume control is commonly used for routine postoperative ventilation. It has the advantage of providing constant minute ventilation but the disadvantage of providing potentially high airway pressures. Pressure control ventilation is used in patients with reduced lung compliance or impaired gas exchange and has the advantage of limiting airway pressures but the disadvantage of providing variable minute ventilation.

Most modern ventilators incorporate hybrid methods of flow generation that produce a constant tidal volume with a decelerating flow pattern. These hybrid forms provide the benefits of pressure control ventilation (decelerating flow, pressure limitation) while ensuring a fixed tidal volume.

Cycling

Cycling refers to the mechanism by which the ventilator changes between inspiration and expiration. Cycling may be time-based or flow-based.

Ventilation Modes

The modes of ventilation form a confusing area. Reference to the manufacturer’s manual usually clarifies the terminology used in discussing a particular ventilator. Only three commonly used modes are discussed here.

Positive End-Expiratory Pressure

PEEP is positive pressure within the alveoli at endexpiration. It is applied by placing a pressure-limiting valve on the expiratory limb of the ventilator circuit. PEEP reduces extravascular lung water, prevents the opening and closing of small airways, and helps to recruit collapsed alveoli. This improves oxygenation, increases lung compliance, and reduces the risk of developing ventilator-induced lung injury.20,21 A low level of PEEP (5 cm H2O) should be applied to all patients who are invasively ventilated. High levels of PEEP (15 to 20 cm H2O) may be required in patients with acute respiratory distress syndrome (ARDS).22 Patients with increased airways resistance whose ventilators are set to an inadequate expiratory time may trap gas and generate auto-PEEP. By applying external PEEP at a level similar to that of the generated auto-PEEP, the inspiratory threshold load (see Fig. 27-4), and therefore the work of breathing, is reduced.

Ventilator Pressures and Graphics

Important information about the patient’s respiratory status may be obtained from the ventilator pressure and graphic displays.

Measured Pressures

Peak Pressure and Plateau Pressure.

Peak pressure is the maximum inspiratory pressure within the breathing circuit. It is affected by both respiratory compliance and airway resistance. Plateau pressure is the pressure within the breathing circuit following an end-inspiratory pause, which allows equalization of any pressure difference between the alveoli and the circuit. Thus, plateau pressure is indicative of alveolar pressure at end inspiration and is influenced by respiratory compliance alone. Plateau pressure may be measured (the patient must be heavily sedated, paralyzed, or both) using the inspiratory hold function on the ventilator or, in volume control mode, estimating it from the pressure-time curve (see Fig. 29-3) when an inspiratory pause or hold is used. Plateau pressure (PP) may be calculated from the respiratory system compliance (C) and the tidal volume (Vt), given:

(29-1) image

Ventilator-induced lung injury is minimized by limiting plateau pressure to less than 32 cm H2O (and peak airway pressure to less than 35 cm H2O).4 However, when chest wall compliance is reduced (e.g., in cases of obesity or abdominal compartment syndrome), a higher plateau pressure may be tolerated (see Fig. 29-1).

With volume control ventilation, high peak and plateau pressures may be due to reduced lung or chest wall compliance (see Figs. 29-1 and 29-3), whereas high peak but normal plateau pressure is indicative of increased airway resistance (see Figs. 29-1 and 29-3).

End-Expiratory Pause Pressure and Auto-PEEP.

End-expiratory pause pressure is the pressure within the circuit following an end-expiratory pause, and it should equal the level of applied PEEP. If end-expiratory pause pressure is greater than the applied PEEP, auto-PEEP exists (Fig. 29-4).23 Auto-PEEP is caused by continued (delayed) emptying of alveoli at end-expiration and indicates increased airway resistance. The presence of auto-PEEP is suggested by continued gas flow at end-expiration on the flow-time curve (see Fig. 29-4).

Causes of auto-PEEP include bronchospasm, blood or mucus within the large airways, or an expiratory time that is too short. High levels of auto-PEEP can cause dynamic lung hyperinflation and cardiovascular collapse. Treatment is described subsequently under the heading Bronchospasm and Obstructive Lung Disease.

Graphic Displays

Most ventilators can display real-time plots of derived respiratory indexes, which may be of assistance in adjusting ventilator settings.24 The most widely used are pressure-time and flow-time curves, dynamic pressure-volume loops, and flow-volume loops.

Pressure-Time and Flow-Time Curves.

Pressure-time and flow-time curves (see Figs. 29-2 to 29-4) are referred to in the earlier sections on flow generation, end-inspiratory pressure, and end-expiratory pressure. They are helpful in diagnosing abnormalities in compliance, resistance, and the presence of auto-PEEP.

The flow-time curve identifies whether flow has fallen to zero at end-expiration and end-inspiration. Continued flow at end-expiration indicates the presence of auto-PEEP (see Fig. 29-4). This may be remedied by increasing the expiratory time, which is usually achieved by reducing the breath rate. Continued flow at end-inspiration with pressure-control ventilation (see Fig. 29-3) may indicate increased airway resistance. It may be remedied by increasing the inspiratory time. However, if auto-PEEP exists as well, this may not be possible, and higher airway pressures may be required.

Dynamic Pressure-Volume Loops.

Dynamic pressure-volume loops (Fig. 29-5) provide a graphic representation of airway pressure against volume in real time for each breath. A dynamic pressure-volume loop differs from a static compliance curve because, in addition to the effect of respiratory system compliance, the effects of airway resistance, circuit resistance, and airflow are included.25

image

Figure 29.5 Pressure-volume loops. A, Two static pressure-volume curves (y and z; see also Fig. 1-15). Lower and upper inflexion points are shown on both curves. Above and below these inflexion points, compliance (ΔV/ΔP, the slope of the curve) is reduced. The lower inflexion point represents the lung volume at which some alveoli’s airways close (closing capacity); the upper inflexion point represents the start of overdistension. In curve y, the lower inflexion point lies below the functional residual capacity (FRC) and no airway closure occurs. In curve z, the inflexion point lies above the FRC, and airway closure will occur unless the FRC is increased by the application of PEEP. B, A dynamic pressure-volume curve is obtained by ventilating the lungs from residual volume (RV) to total lung capacity (TLC) when airways resistance is trivial. Hysteresis, in which lung volumes are different for a given pressure during inspiration and expiration is shown. Hysteresis is partly (but not solely) due to airway resistance. C, A dynamic pressure-volume curve is obtained when lungs are ventilated with a normal tidal volume from the FRC and airway resistance is normal. No inflexion points are seen, indicating no airway closure or overdistension. The shaded areas represent work to overcome respiratory system compliance (vertical hatch) and airway resistance (horizontal hatch). D, A dynamic pressure-volume curve with a lower inflexion point is indicative of inadequate PEEP. If a static pressure-volume curve were obtained, the FRC would be below the lower inflection point (curve z, A). E, A dynamic pressure-volume curve with an upper inflexion point is indicative of overinflation. This is termed “beaking.” F, The effect on the dynamic pressure-volume curve of increased airway resistance. Peak airway pressure (PAWP) and work of breathing (hatched areas) are increased because of the increased airway resistance. If expiration is active, the expiratory part of the curve will resemble the line labeled AE. Work done during active expiration is represented diagrammatically by the area labeled active exhalation work.

On a static respiratory system compliance curve (see Figs. 1-15 and 29-5A), upper and lower inflexion points can be identified. The upper inflexion point identifies overdistension of alveoli; the lower inflexion point identifies closing capacity. Ideally, the lungs should be ventilated between these two inflexion points, on the steep part of their compliance curves; that is, FRC should be above the lower inflexion point (as shown in Fig. 29-5A, curve y). The construction of a static compliance curve is impractical for routine care, and dynamic compliance curves are used instead (see Fig. 29-5B and C). Some ventilators can create an approximation of a static compliance curve by using the dynamic compliance curves generated by breaths of differing tidal volumes.

Inflexion points may be visible on dynamic-pressure volume curves but often they are not obvious. The presence of a lower inflexion point (see Fig. 29-5D) may indicate insufficient PEEP, whereas the presence of an upper inflexion point (see Fig. 29-5E) usually indicates overdistension due to excessive tidal volume. In patients ventilated appropriately with adequate PEEP and normal tidal volumes (6 to 8 ml/kg), ideally no inflexion points should be seen (see Fig. 29-5C). Changes in the dynamic pressure-volume loop that occur with increased airway resistance are shown in Figure 29-5F.

Managing Impaired Gas Exchange

Ventilator Management

Altering Respiratory Rate.

With increased airflow resistance, decreasing the respiratory rate to 6 to 8 breaths per minute reduces the risk of air trapping and dynamic lung hyperinflation.28 In restrictive lung disease (atelectasis, pulmonary edema, pneumonia, etc.), increasing the respiratory rate to 15 to 20 breaths per minute may improve gas exchange.

VENTILATORY STRATEGIES

Simple Adjuvant Therapies

Humidification

Humidification (see Chapter 28) of respiratory gases is essential to maintain mucociliary function and to prevent mucus plugging of large airways. Heat and moisture exchangers attached to the end of the endotracheal tube are suitable for use in patients who are mechanically ventilated for up to 48 hours.29 For patients who are ventilated for longer than 48 hours, a heated water-bath humidifier should be used.

Advanced Adjuvant Therapies

Recruitment Maneuvers

Recruitment maneuvers may be helpful in reopening collapsed alveoli.32 A recruitment maneuver involves the application of 30 to 40 cm H2O PEEP for 30 to 40 seconds. During the maneuver, patients should be heavily sedated or paralyzed so as to avoid respiratory effort. The maneuver may need to be terminated early if the patient develops severe hypotension or hypoxemia. Following the maneuver, PEEP is set to a very high level (20 to 25 cm H2O) and reduced in 2.5-cm-H2O increments every 10 minutes while observing the effect on gas exchange. The level of PEEP at which oxygenation deteriorates is the point at which airways closure is occurring. The recruitment maneuver should then be repeated and PEEP applied at a level just above that at which airway closure occurs. If no benefit is observed as a result of the intervention, no further recruitment maneuvers should be performed.33

A recruitment maneuver may be considered in a patient who requires an FIo2 greater than 60% and PEEP greater than 10 cm H2O for a sustained period. Benefit from a recruitment maneuver is most likely in patients with atelectasis and ARDS. It is more effective in the prone position. In the setting of hypovolemia or ventricular dysfunction, recruitment maneuvers can cause severe hypotension and must be performed with extreme caution.

Prone Positioning

Atelectasis is most likely to affect dependent pulmonary segments (see Fig. 27-2) which, because of the effects of gravity, are also the regions that receive preferential blood flow. With prone positioning, atelectatic regions are predominantly nondependent, and dependent regions are well ventilated and well perfused, which reduces intrapulmonary shunting. Prone positioning for 6 hours has been shown to improve oxygenation in 70% of patients with ARDS or acute lung injury (ALI),34 but a survival benefit has not been clearly demonstrated.35 Patients with ARDS of nonpulmonary origin (e.g., sepsis) obtain the greatest benefit. Prone positioning for 6- to 12-hour periods, alternating with 6- to 12-hour periods of supine positioning, may be considered in patients who require an FIo2 above 60% and PEEP above 10 cm H2O for a sustained period. If benefits are obtained, it should be continued until the FIo2 is less than 40% to 50% and PEEP less than 10 cm H2O.

In the prone position, the patient must be supported, e.g., by pillows, under the chest and pelvis, leaving the abdomen free for respiratory excursion. The patient’s head should be supported primarily under the forehead. The eyes, nose, lips, airway, breasts, and genitals must be carefully inspected for pressure points or compression. Lifting and turning large adult patients require a coordinated effort by at least five people.

Inhaled Nitric Oxide

Inhaled nitric oxide is a potent pulmonary vasodilator that is used to treat severe pulmonary hypertension and right ventricular failure (see Chapter 24).37 Because inhaled nitric oxide is delivered only to ventilated regions of the lung, it also improves V/Q matching within the lung. Doses of 5 to 40 parts per million improve oxygenation in some patients with ARDS. However, the benefit is sustained for only 24 to 48 hours, and no improvement in patient outcome has been demonstrated.38 Inhaled nitric oxide may be considered in patients with severely impaired gas exchange that is resistant to other ventilatory measures. Sudden cessation of nitric oxide can cause marked hypoxemia and increased pulmonary vascular resistance, which can precipitate right ventricular failure.

Corticosteroids

With the exception of bronchospasm, corticosteroids have no role in the management of acute respiratory failure. There are conflicting data concerning the role of corticosteroids in persistent ARDS. One small, randomized trial involving only 24 patients demonstrated a marked survival benefit in patients with severe ARDS who had failed to improve by the seventh day of respiratory failure.39 However, a recent randomized trial involving 180 patients did not demonstrate any difference in survival rates in patients with ARDS of at least 7 days’ duration between those who were treated with methylprednisolone (2 mg/kg then 0.5 mg/kg every 6 hours for 14 days with subsequent tapering of the dosage) and those who were treated with placebo.40 Also, mortality rates were higher in the treatment group when methylprednisolone was started 2 or more weeks after the onset of ARDS. Some secondary outcomes, such as measures of gas exchange and number of ventilator days, were, however, better in steroid-treated patients. Routine use of corticosteroids for ARDS is not recommended.41

Specific Clinical Scenarios

Hypoxemia in the Early Postoperative Period

Occasionally, patients arrive from the operating room in a state of hypoxemia or hypoxemia rapidly develops in the ICU. Initial management is to rule out a life-threatening or easily correctable cause. The patient (along with the ventilator and breathing circuit) should be examined, and the postoperative chest radiograph should be reviewed. The common causes of hypoxemia in this situation are listed in Table 27-1.

Sometimes no cause for the hypoxemia is identified: the lungs are easy to ventilate, the chest radiograph is unremarkable, and Paco2 and pH are normal. This situation usually represents a combination of the adverse effects of positive pressure ventilation on V/Q matching, microatelectasis, impaired hypoxic pulmonary vasoconstriction, increased extravascular lung water, and low Svo2. It may be useful to suction the endotracheal tube and provide a gentle recruitment maneuver. Depending on the severity of the hypoxemia, no specific treatment may be required and the problem usually resolves over a few hours. If intervention is required, the following should be considered: (1) increasing PEEP; (2) stopping drugs that impair hypoxic pulmonary vasoconstriction; (3) using a decelerating inspiratory flow pattern; (4) increasing inspiratory time to more than 1.5 seconds; (5) deep sedation and paralysis. Superior vena cava oxygen saturation (SSVCo2) should be measured. Pulmonary artery catheterization, an echocardiogram, or both should be performed if there is hemodynamic instability or if SSVCo2 is low (see Chapter 20).

Bronchospasm and Obstructive Lung Disease

Severe bronchospasm is a medical emergency. However, before a patient is treated for bronchospasm, other causes of ventilatory difficulty should be ruled out, particularly heart failure, mechanical airway obstruction, and pneumothorax. Bronchospasm may be precipitated by tracheal suctioning, by the lightening of sedation, or because the tip of the endotracheal tube has touched the carina.

The two major risks involved in invasive ventilation in patients with severe bronchospasm are (1) cardiovascular collapse secondary to dynamic lung hyperinflation and (2) tension pneumothorax. Dynamic lung hyperinflation may be avoided by ventilating with low breath rates and long expiratory times. Ventilation with a low minute volume (accepting a high Paco2) and maintenance of a normal inspiratory time minimize peak airway pressures. High peak airway pressures in this setting are not indicative of high transalveolar pressures (see Fig. 29-1); peak airway pressures above 35 cm H2O are preferable to shortening the expiratory time because the risk for barotrauma arises mainly from dynamic pulmonary hyperinflation or rupture of a bulla.

The following initial ventilator settings are appropriate for severe bronchospasm:

Bronchodilators may be administered into the ventilator circuit by nebulization or metered dose inhaler (see Chapter 28). In cases of hemodynamic collapse in which dynamic lung hyperinflation is suspected, the patient should be disconnected from the ventilator for 30 to 40 seconds to allow full expiration to occur (the “Lazarus maneuver”).

Cardiac Failure

Positive pressure ventilation reduces left ventricular afterload (see Chapter 1) and decreases extravascular lung water (pulmonary edema), which is beneficial in patients with left ventricular dysfunction. In the first instance, patients may respond to noninvasive ventilation (see Chapter 28). If invasive ventilation is required, no specific mode is recommended but high PEEP (>10 cm H2O) is rarely required. With pulmonary edema, disconnections from the ventilator to allow tracheal suctioning should be kept to an absolute minimum. Not only is suctioning ineffective in controlling pulmonary edema, but disconnecting the ventilator results in the loss of PEEP, which allows further extravasation of edema fluid.

The effects of positive pressure ventilation on right ventricular function are variable. High intrathoracic pressure may cause marked hypotension due to reduced right ventricular preload and increased right ventricular afterload. However, if positive pressure ventilation improves gas exchange and maintains FRC, right ventricular function may improve because of a fall in right ventricular afterload.

ALI/ARDS and Lung-Protective Ventilation

Severe ARDS is relatively rare in cardiac surgery patients, but it may be encountered more frequently if the ICU functions as a referral center for extracorporeal membrane oxygenation (ECMO). ARDS is characterized by reduced lung compliance, impaired gas exchange, and a high risk for barotrauma (see Chapter 27). The goals in ventilating patients with ARDS are to sustain life while lung function recovers and to avoid ventilator-induced lung injury. The following ventilator settings and physiologic goals are appropriate:

pH and Paco2. This ventilatory strategy is likely to result in hypercarbia and respiratory acidosis. However, there is no evidence that even severe hypercarbia causes significant morbidity and, in fact, it may be beneficial.42 Whereas a pH less than 7.05 to 7.1 should probably be avoided, a pH of 7.2 is preferable to high airway pressures. With normal renal function, metabolic compensation for a respiratory acidosis develops over a few days, allowing a very high Paco2 (>10 κPa or 76 mmHg) to be associated with a pH above 7.2.

The adjuvant ventilatory and nonventilatory strategies outlined should be considered, particularly recruitment maneuvers, prone positioning, inhaled nitric oxide, and reduction of metabolic rate. The strategy of small tidal volume ventilation with permissive hypercarbia is known as lung-protective ventilation, and it improves survival rates in patients with ARDS.7 For patients with life-threatening respiratory failure despite the treatment outlined, high-frequency oscillation or venovenous ECMO should be considered.

High-Frequency Oscillation

Patients with potentially reversible acute respiratory failure are occasionally unable to be kept alive with conventional ventilation. This most commonly occurs following lung transplantation and in patients with severe pneumonia complicated by ARDS. Such patients may be considered for either high-frequency oscillation or venovenous ECMO (see Chapter 22). High-frequency oscillation should be considered prior to ECMO in patients who fulfill ECMO criteria (see Chapter 22) but do not have severe hemodynamic instability.

A high-frequency oscillator contains a piston that moves back and forth rapidly as fresh gas (the bias gas flow) passes in front of it. The ventilator generates a constant positive airway pressure onto which small tidal breaths (<2 ml/kg) at very high rates (300 to 900/min) are superimposed.43 The constant positive airway pressure helps to recruit closed alveoli and therefore improves oxygenation, and the rapid, small breaths (oscillations) remove carbon dioxide.44

Patients may deteriorate for a short time when first placed on the oscillator and may take several hours to show improvement. The benefit of high-frequency oscillation is lost if there are frequent disconnections from the ventilator for suctioning. The following are typical adult settings:

Oxygenation is determined largely by FIo2 and mean airway pressure, and these should be altered if Pao2 is unacceptably low. Carbon dioxide elimination is determined mainly by breath rate and to a lesser extent by bias flow and power. If hypercarbia and acidosis are severe, breath rate (frequency) should be decreased and power (amplitude) may be increased. If the patient has severe respiratory acidosis despite these maneuvers, deflating the cuff on the endotracheal tube to allow a small air leak may result in improved elimination of carbon dioxide.

Once the patient has been established on highfrequency oscillation, he or she should be weaned to an FIo2 of 0.6. Next, mean airway pressure should be reduced in steps of 2 cm H2O. This should be performed slowly so as to avoid airway closure. Once mean airway pressure is 10 to 14 cm H2O, the patient may be converted to conventional ventilation.

Ventilator Alarms

The causes and treatment of commonly employed alarms are listed in Table 29-1.

Table 29-1 Ventilator Alarms

Alarm Possible Causes Interventions
High airway pressure with VC or low tidal volume with PC Mucus plugging Suction ETT
    Consider saline lavage
  Blocked circuit or HME Ventilate with manual resuscitator, change HME and circuit
  Endobronchial intubation Review CXR and withdraw ETT
  Obesity Have patient sit up
    Accept higher airway pressure
  Patient-ventilator dysynchrony Reassure patient
    Adjust ventilator settings (see text)
    Sedate and/or paralyze
  Increased airway resistance ± dynamic lung hyperinflation Examine patient and ventilator graphics to confirm increased resistance ± auto-PEEP
    Reduce breath rate and ensure adequate It and Et
    Treat bronchospasm if present
    Treat bronchospasm if present
    Suction if mucus plugging exists
    Decrease set PEEP
    In emergency: disconnect patient from ventilator for 30 seconds
  New lung disease causing reduced compliance (e.g., pulmonary edema, hemothorax, pneumothorax) Examine patient and check ventilator graphics (see text)
    Review CXR
    Treat specific pathology (see text)
  Blocked expiratory valve Disconnect patient from ventilator
    Hand ventilate with manual resuscitator
Low expired minute volume Spontaneous mode: apnea or hypoventilation Change to mandatory ventilation mode
  Mandatory mode: cuff leak, circuit disconnection, large air leak from lung Examine patient, circuit, and ventilator for leak
    Check chest drains for bubbling; if present, consider reducing suction/lung isolation/surgery
High expired minute volume Hyperventilation, autotriggering, excessive pressure support or mandatory ventilation Examine patient
    Ensure patient is not developing metabolic acidosis
    Check that ventilator settings are appropriate
    Treat respiratory alkalosis as appropriate (see text for details)
High respiratory rate Autotriggering: Water in the ventilator circuit, patient movement, hyperdynamic cardiac impulse, large cuff leak Remove water from circuit
    Sedate patient
    Inflate cuff
  Inadequate respiratory support from ventilator Decrease trigger sensitivity
    Increase trigger sensitivity
    Increase ventilatory support
  Inadequate sedation Optimize sedation

CXR, chest radiograph; Et, expiratory time; ETT, endotracheal tube; HME, heat and moisture exchanger; It, inspiratory time; PC, pressure control; VC, volume control; PEEP, positive end expiratory pressure.

Weaning From Ventilation

For routine cardiac surgery patients, weaning from invasive ventilation is not required. Rather, sedation is stopped and, once patients begin making respiratory efforts, they are changed to a spontaneous breathing mode and extubated when awake (see Chapter 17).

Prolonged invasive ventilation for serious respiratory or cardiac disease involves two phases: (1) rest and repair; (2) recovery and retraining. During rest and repair, the aim is to reduce the work of breathing, provide adequate gas exchange, and avoid ventilator-induced lung injury. Patients are typically sedated but routine neuromuscular paralysis is not indicated because it prolongs the duration of invasive ventilation and increases the risk for critical illness polymyoneuropathy. Assist/control and SIMV with pressure support are commonly used modes during the rest and repair phase. Weaning (the recovery and retraining phase) is commenced once certain criteria have been met (Table 29-2).45

image

Table 29-2 Criteria for Commencing Weaning of Ventilatory Support

Rights were not granted to include this table in electronic media. Please refer to the printed book.

From MacIntyre NR, Cook DJ, Ely EW Jr, et al: Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitatd by the American College of Chest Physicians, the American Association for Respiratory Care, and the American College of Critical Care Medicine. Chest 120:375S-395S, 2001. PEEP, positive end-expiratory pressure.

Methods of Weaning

Multiple ventilatory techniques have been used to facilitate weaning. They include: (1) assist/control mode; (2) SIMV with a gradual reduction in the breath rate; (3) pressure support mode with a gradual reduction in the level of support; (4) frequent trials of spontaneous breathing. Trials of spontaneous breathing or a gradual reduction in the level of pressure support result in shorter periods of ventilation than does an SIMV-based weaning strategy.46 In one study, trials of spontaneous breathing were superior to gradual reductions in pressure support.47

Regardless of the weaning technique, the following should be borne in mind. First, the use of a protocol shortens weaning time.48 Second, the time required for weaning varies considerably among patients, from a few hours to longer than a month. Thus, clinicians must be prepared to modify weaning plans according to individual patients’ responses. Third, patients should never be allowed to exhaust themselves because it causes a loss of muscle strength that may require a further period of rest and recovery before weaning can be attempted again.

Failure to Wean

Any correctable respiratory problems should be identified and treated. This may require diagnostic chest ultrasound, chest computed tomography, diaphragmatic screening, and bronchoscopy. Pneumothoraces and significant pleural collections (>300 to 400 ml on ultrasound) should be drained. Pulmonary edema should be treated with diuretics. Pneumonia should be actively sought and treated with appropriate antibiotics. Lobar collapse and basal atelectasis may be treated with bronchoscopy-guided suctioning and chest physical therapy, which may include postural drainage and incentive spirometry. Treatment of phrenic nerve injury is usually supportive but occasionally diaphragmatic plication is required.

Cardiac dysfunction is a common cause of failure to wean.49 A patients who is difficult to wean should undergo an echocardiogram. If left ventricular systolic function is impaired, treatment with angiotensin-converting enzyme inhibitors, digoxin, furosemide, and spironolactone may facilitate weaning. Significant pericardial collections should be drained.

Excessive fluid administration can increase extravascular lung water and impair respiratory function. Also, patients receiving positive pressure ventilation tend to retain sodium and water. Daily water requirements are low in ventilated patients—about 20 ml/kg/day (see Chapter 32). The daily fluid balance should be closely scrutinized, and treatment with furosemide may be warranted even if cardiac function is normal.

Optimal nutrition is vital during weaning. Excess calories,50 particularly in the form of carbohydrates,51 increase carbon dioxide production and increase respiratory work. Too few calories prolong weakness and contribute to ventilator dependence.

Critical illness polymyoneuropathy (see Chapter 37) is a common cause of prolonged weaning. Treatment is supportive, and exacerbating factors, such as the use of corticosteroids and neuromuscular blockers, should be kept to a minimum.

Patients who have suffered a neurologic insult as a result of cardiac surgery may be difficult to wean because of weakness, agitation, or depressed consciousness.

Extubation

Numerous indexes have been proposed for predicting successful extubation (Table 29-3), but none have high positive predictive values.52 Prior to extubation, patients should be breathing comfortably and have satisfactory respiratory rates, tidal volumes, oxygenation (Pao2/FIo2 >20 κPa or 150 mmHg), and cough. They should be able to obey simple commands.

image

Table 29-3 Predictors of Successful Extubation

Rights were not granted to include this table in electronic media. Please refer to the printed book.

From MacIntyre NR, Cook DJ, Ely EW Jr, et al: Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 120:375S-395S, 2001.

Tracheotomy

Every patient who is ventilated for longer than 7 to 10 days should be considered for a tracheotomy, ideally at the beginning of the recovery and retraining phase.53 Early tracheotomy (within the first week) may reduce the total number of days on the ventilator.54 A tracheotomy provides greatly increased tolerance of ventilation, more effective clearance of secretions, the ability to remove and reinstitute invasive ventilation easily, and the potential to speak and eat.45 The main disadvantages of tracheotomies are procedure related. Tracheotomies do not increase the incidence of sternal wound infection or mediastinitis in cardiac surgery patients.5557 Percutaneous insertion is at least as safe as open surgical placement58 and has the advantage of being able to be performed at the bedside. The technique of percutaneous tracheotomy is described in Chapter 40.

Management of Tracheotomies

A large-sized tracheotomy tube—typically 9 mm internal diameter for males and 8 mm internal diameter for females—should be used so as to minimize airway resistance. Initially, a nonfenestrated tube with a high-volume, low-pressure cuff should be used. The cuff should be inflated during positive pressure ventilation but may be deflated during periods of T-tube breathing. An inner tube may be used; it has the advantage of being able to be removed and cleaned. Adequate humidification of inspired gas should be provided by a heated water-bath (see Chapter 28); heat and moisture exchangers are suitable only for short-term use, and they impose increased circuit resistance.

In the case of a correctly placed tube of appropriate size, no airway leak should occur with a cuff pressure of less than 20 cm H2O and a volume of less than 10 ml. Cuff pressure should be checked regularly with a manometer. The presence of an airway leak despite appropriate cuff volume and pressure suggests that the tracheotomy tube has become partially dislodged (see Chapter 40).

With percutaneous insertion, routine changes of the tracheotomy tube are not recommended, particularly in the first few days, because the tube is likely to be tightfitting and the track not well formed. If the tube becomes dislodged or blocked, it may be impossible to reposition it, even with aid of a bronchoscope. Facilities for orotracheal intubation should be immediately available during any manipulations of a tracheotomy tube.

Swallowing and Eating.

Between 30% and 50% of patients with tracheotomies are observed to aspirate when swallowing is examined by video fluoroscopy, irrespective of whether or not the cuff is inflated. In 80% of cases, aspiration is clinically silent.59,60 During swallowing, a tracheotomy tube prevents normal laryngeal elevation, which is one of the mechanisms of protecting the airway from soiling by food particles. The inflated tracheotomy tube cuff also alters upper esophageal function and predisposes to aspiration. Patients with tracheotomies are often weak, with poor cough and impaired vocal cord function. Thus, patients should not routinely be fed orally; rather, nutrition should be provided via a fine-bore nasogastric or nasojejunal tube. However, during prolonged weaning, eating may significantly enhance a patient’s mood and oral comfort and the desire to get better. If a decision is made to offer a trial of feeding, the patient should be helped into a sitting position, the cuff deflated, and a small volume of soft food offered; soft food is less likely to be aspirated than is a liquid.

REFERENCES

1 Fessler HE. Heart-lung interactions: applications in the critically ill. Eur Respir J. 1997;10:226-237.

2 Auler JOJr, Carmona MJ, Barbas CV, et al. The effects of positive end-expiratory pressure on respiratory system mechanics and hemodynamics in postoperative cardiac surgery patients. Braz J Med Biol Res. 2000;33:31-42.

3 Gattinoni L, Carlesso E, Cadringher P, et al. Physical and biological triggers of ventilator-induced lung injury and its prevention. Eur Respir J. 2003;47(suppl):S15-S25.

4 Adams AB, Simonson DA, Dries DJ. Ventilator-induced lung injury. Respir Care Clin North Am. 2003;9:343-362.

5 Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282:54-61.

6 Pinhu L, Whitehead T, Evans T, et al. Ventilator-associated lung injury. Lancet. 2003;361:332-340.

7 The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-1308.

8 van den Berg PC, Grimbergen CA, Spaan JA, et al. Positive pressure inspiration differentially affects right and left ventricular outputs in postoperative cardiac surgery patients. J Crit Care. 1997;12:56-65.

9 Vieillard-Baron A, Loubieres Y, Schmitt JM, et al. Cyclic changes in right ventricular output impedance during mechanical ventilation. J Appl Physiol. 1999;87:1644-1650.

10 Steingrub JS, Tidswell M, Higgins TL. Hemodynamic consequences of heart-lung interactions. J Intens Care Med. 2003;18:92-99.

11 Koganov Y, Weiss YG, Oppenheim A, et al. Positive end-expiratory pressure increases pulmonary venous vascular resistance in patients after coronary artery surgery. Crit Care Med. 1997;25:767-772.

12 Pacher R, Frass M, Hartter E, et al. The role of alpha-atrial natriuretic peptide in fluid retention during mechanical ventilation with positive end-expiratory pressure. Klin Wochenschrift. 1986;64(suppl 6):64-67.

13 Kapadia F. Mechanical ventilation: simplifying the terminology. Postgrad Med J. 1998;74:330-335.

14 Branson RD, Johannigman JA. What is the evidence base for the newer ventilation modes ? Respir Care. 2004;49:742-760.

15 Tobin MJ. Advances in mechanical ventilation. N Engl J Med. 2001;344:1986-1996.

16 Rappaport SH, Shpiner R, Yoshihara G, et al. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med. 1994;22:22-32.

17 Blanch L, Bernabe F, Lucangelo U. Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients. Respir Care. 2005;50:110-123.

18 Malarkkan N, Snook NJ, Lumb AB. New aspects of ventilation in acute lung injury. Anaesthesia. 2003;58:647-667.

19 Branson R. Understanding and implementing advances in ventilator capabilities. Curr Opin Crit Care. 2004;10:23-32.

20 Colmenero-Ruiz M, Fernandez-Mondejar E, Fernandez-Sacristan MA, et al. PEEP and low tidal volume ventilation reduce lung water in porcine pulmonary edema. Am J Respir Crit Care Med. 1997;155:964-970.

21 Fernandez Mondejar E, Vazquez Mata G, Cardenas A, et al. Ventilation with positive end-expiratory pressure reduces extravascular lung water and increases lymphatic flow in hydrostatic pulmonary edema. Crit Care Med. 1996;24:1562-1567.

22 Suh GY, Kwon OJ, Yoon JW, et al. A practical protocol for titrating “optimal” PEEP in acute lung injury: recruitment maneuver and PEEP decrement. J Korean Med Sci. 2003;18:349-354.

23 Brochard L. Intrinsic (or auto-) positive end-expiratory pressure during spontaneous or assisted ventilation. Intens Care Med. 2002;28:1552-1554.

24 Burns SM. Working with respiratory waveforms: how to use bedside graphics. AACN Clin Issues. 2003;14:133-144.

25 Lu Q, Rouby JJ. Measurement of pressure-volume curves in patients on mechanical ventilation: methods and significance. Crit Care. 2000;4:91-100.

26 Jenkinson SG. Oxygen toxicity. New Horiz. 1993;1:504-511.

27 Campbell RS, Davis BR. Pressure-controlled versus volume-controlled ventilation: does it matter ? Respir Care. 2002;47:416-424.

28 Conrad SA, Zhang S, Arnold TC, et al. Protective effects of low respiratory frequency in experimental ventilator-associated lung injury. Crit Care Med. 2005;33:835-840.

29 Nakagawa NK, Macchione M, Petrolino HM, et al. Effects of a heat and moisture exchanger and a heated humidifier on respiratory mucus in patients undergoing mechanical ventilation. Crit Care Med. 2000;28:312-317.

30 Vonberg RP, Eckmanns T, Welte T, et al. Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials. Intens Care Med. 2006;32:1329-1335.

31 Raymond SJ. Normal saline instillation before suctioning: helpful or harmful ? A review of the literature. Am J Crit Care. 1995;4:267-271.

32 Hess DR, Bigatello LM. Lung recruitment: the role of recruitment maneuvers. Respir Care. 2002;47:308-317.

33 Marini JJ. Recruitment maneuvers to achieve an ‘open lung’ —whether and how ? Crit Care Med. 2001;29:1647-1648.

34 Gattinoni L, Tognoni G, Brazzi L, et al. Ventilation in the prone position. The Prone-Supine Study Collaborative Group. Lancet. 1997;350:815.

35 Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345:568-573.

36 Nahum A. Tracheal gas insufflation as an adjunct to mechanical ventilation. Respir Care Clin North Am. 2002;8:171-185.

37 Bender KA, Alexander JA, Enos JM, et al. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery. Am J Crit Care. 1997;6:127-131.

38 Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291:1603-1609.

39 Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159-165.

40 Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671-1684.

41 Suter PM. Lung inflammation in ARDS—friend or foe ? N Engl J Med. 2006;354:1739-1742.

42 Ni Chonghaile M, Higgins B, Laffey JG. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care. 2005;11:56-62.

43 Chan KP, Stewart TE. Clinical use of high-frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome. Crit Care Med. 2005;33:S170-S174.

44 Pillow JJ. High-frequency oscillatory ventilation: mechanisms of gas exchange and lung mechanics. Crit Care Med. 2005;33:S135-S141.

45 MacIntyre NR, Cook DJ, Ely EWJr, et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest. 2001;120:375S-395S.

46 Meade M, Guyatt G, Sinuff T, et al. Trials comparing alternative weaning modes and discontinuation assessments. Chest. 2001;120:425S-437S.

47 Esteban A, Frutos F, Tobin MJ, et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med. 1995;332:345-350.

48 Meade MO, Guyatt GH, Cook DJ. Weaning from mechanical ventilation: the evidence from clinical research. Respir Care. 2001;46:1408-1415.

49 Richard C, Teboul JL. Weaning failure from cardiovascular origin. Intens Care Med. 2005;31:1605-1607.

50 van den Berg B, Stam H. Metabolic and respiratory effects of enteral nutrition in patients during mechanical ventilation. Intens Care Med. 1888;14:206-211.

51 Cook D, Meade M, Guyatt G, et al. Trials of miscellaneous interventions to wean from mechanical ventilation. Chest. 2001;120:438S-444S.

52 Conti G, Montini L, Pennisi MA, et al. A prospective, blinded evaluation of indexes proposed to predict weaning from mechanical ventilation. Intens Care Med. 2004;30:830-836.

53 Heffner JE. The role of tracheotomy in weaning. Chest. 2001;120:477S-481S.

54 Griffiths J, Barber VS, Morgan L, et al. Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ. 2005;330:47-1243.

55 Borger MA, Rao V, Weisel RD, et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg. 1998;65:1050-1056.

56 Byhahn C, Rinne T, Halbig S, et al. Early percutaneous tracheostomy after median sternotomy. J Thorac Cardiovasc Surg. 2000;120:329-334.

57 Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery —an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg. 2002;50:87-91.

58 Freeman BD, Isabella K, Lin N, et al. A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients. Chest. 2000;118:1412-1418.

59 Elpern EH, Scott MG, Petro L, ET AL. Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest. 1994;105:563-566.

60 Leder SB. Incidence and type of aspiration in acute care patients requiring mechanical ventilation via a new tracheotomy. Chest. 2002;122:1721-1726.